{ "cik": 1743881, "cik_padded": "0001743881", "entityName": "BridgeBio Pharma, Inc.", "fiscal_years": [ { "accn": "0001743881-26-000009", "filed": "2026-02-24", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 48276000.0, "capex": 1097000.0, "cash": 570119000.0, "eps_diluted": -3.78, "free_cash_flow": -447007000.0, "net_income": -732938000.0, "operating_cash_flow": -445910000.0, "operating_income": -523411000.0, "revenue": 502076000.0, "stockholders_equity": -2086610000.0, "total_assets": 936025000.0, "total_liabilities": 3012606000.0 }, "period_end": "2025-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -1.4598148487479983, "operating_margin": -1.0424935667110158, "revenue_growth_yoy": 1.262602410072915, "roa_avg2y": -0.7900750419190207, "roa_period_end": -0.7830325044737053, "roe_avg2y": 0.41239843196566395 } }, { "accn": "0001743881-26-000009", "filed": "2026-02-24", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 933000.0, "cash": 681101000.0, "eps_diluted": -2.88, "free_cash_flow": -521659000.0, "net_income": -543347000.0, "operating_cash_flow": -520726000.0, "operating_income": -592973000.0, "revenue": 221902000.0, "stockholders_equity": -1467904000.0, "total_assets": 919338000.0, "total_liabilities": 2376950000.0 }, "period_end": "2024-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 22.852735676663443, "roa_avg2y": -0.7414072829834935, "roa_period_end": -0.5910198425388704, "roe_avg2y": 0.38505740813511347 } }, { "accn": "0001743881-26-000009", "filed": "2026-02-24", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 1306000.0, "cash": 375935000.0, "eps_diluted": -3.95, "free_cash_flow": -529026000.0, "net_income": -653251000.0, "operating_cash_flow": -527720000.0, "operating_income": -607370000.0, "revenue": 9303000.0, "stockholders_equity": -1354257000.0, "total_assets": 546380000.0, "total_liabilities": 1888915000.0 }, "period_end": "2023-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.8801900886049866, "roa_avg2y": -1.1172260341914255, "roa_period_end": -1.1955983015483729, "roe_avg2y": 0.5007915292191191 } }, { "accn": "0000950170-25-024119", "filed": "2025-02-20", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 4821000.0, "cash": 376689000.0, "eps_diluted": -3.26, "free_cash_flow": -424315000.0, "net_income": -484652000.0, "operating_cash_flow": -419494000.0, "operating_income": -512202000.0, "revenue": 77648000.0, "stockholders_equity": -1254617000.0, "total_assets": 623036000.0, "total_liabilities": 1867960000.0 }, "period_end": "2022-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 0.11377589075678467, "roa_avg2y": -0.592546404634228, "roa_period_end": -0.7778876341014002, "roe_avg2y": 0.45613640459833293 } }, { "accn": "0000950170-24-018811", "filed": "2024-02-22", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 200000000.0, "capex": 13246000.0, "cash": 393772000.0, "eps_diluted": -3.9, "free_cash_flow": -511180000.0, "net_income": -586454000.0, "operating_cash_flow": -497934000.0, "operating_income": -576632000.0, "revenue": 69716000.0, "stockholders_equity": -870414000.0, "total_assets": 1012792000.0, "total_liabilities": 1878371000.0 }, "period_end": "2021-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 7.45144866044369, "roa_avg2y": -0.6833614933755928, "roa_period_end": -0.5790468329133721, "roe_avg2y": 1.4435648633613454 } }, { "accn": "0000950170-23-004145", "filed": "2023-02-23", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 75000000.0, "capex": 7518000.0, "cash": 356082000.0, "eps_diluted": -3.8, "free_cash_flow": -407232000.0, "net_income": -505488000.0, "operating_cash_flow": -399714000.0, "operating_income": -474482000.0, "revenue": 8249000.0, "stockholders_equity": 57906000.0, "total_assets": 703588000.0, "total_liabilities": 595702000.0 }, "period_end": "2020-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.7966222879684418, "roa_avg2y": -0.757133966465134, "roa_period_end": -0.7184431798154601, "roe_avg2y": -2.167801698258856 } }, { "accn": "0000950170-22-002030", "filed": "2022-02-25", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2638000.0, "cash": 363773000.0, "free_cash_flow": -256225000.0, "net_income": -288585000.0, "operating_cash_flow": -253587000.0, "operating_income": -266240000.0, "revenue": 40560000.0, "stockholders_equity": 408454000.0, "total_assets": 631679000.0, "total_liabilities": 155703000.0 }, "period_end": "2019-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.5263172293045905, "roa_period_end": -0.4568538767316944, "roe_avg2y": -0.7979312432862873 } }, { "accn": "0001564590-21-008969", "filed": "2021-02-25", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2178000.0, "cash": 436086000.0, "free_cash_flow": -138821000.0, "net_income": -169451000.0, "operating_cash_flow": -136643000.0, "operating_income": -183660000.0, "stockholders_equity": 314879000.0, "total_assets": 464941000.0, "total_liabilities": 87579000.0 }, "period_end": "2018-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_period_end": -0.36445699561879896, "roe_avg2y": -0.8457115763731191 } }, { "accn": "0001564590-20-008260", "filed": "2020-03-03", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD" }, "fundamentals": { "capex": 464000.0, "cash": 91995000.0, "free_cash_flow": -40952000.0, "net_income": -43832000.0, "operating_cash_flow": -40488000.0, "operating_income": -43858000.0, "stockholders_equity": 85851000.0 }, "period_end": "2017-12-31", "ratio_units": { "roe_avg2y": "ratio" }, "ratios": { "roe_avg2y": -0.8702005161802661 } }, { "accn": "0001564590-20-008260", "filed": "2020-03-03", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": 14889000.0 }, "period_end": "2016-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001743881-26-000009", "filed": "2026-02-24", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001743881.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001743881.json" }, "ticker": "BBIO" }